Trial Profile
Difference in blood lapatinib concentration under pre or post prandial fasting states in patients with breast cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Pharmacokinetics
- 10 Jul 2017 New trial record
- 26 Jun 2017 Results published in the Annals of Oncology